KCNB1 Membrane Protein Introduction

Introduction of KCNB1

KCNB1, also known as Kv2.1, is a member of the potassium channel, voltage-gated, shab-related subfamily. It is encoded by the KCNB1 gene and has 858 amino acid residues. The structure analysis of KCNB1 indicates that it has 6 transmembrane spanning regions labeled S1-S6, each with a tetrameric structure. The p-loop is created by S5 and S6. The S4 contains a voltage sensor. KCNB1 is expressed in the nervous system, heart, skeletal muscle, pulmonary arteries, and pancreas.

Basic Information of KCNB1
Protein Name Potassium voltage-gated channel subfamily B member 1
Gene Name KCNB1
Aliases DRK1, Kv2.1
Organism Homo sapiens (Human)
UniProt ID Q14721
Transmembrane Times 6
Length (aa) 858

Function of KCNB1 Membrane Protein

KCNB1 is a delayed rectifier voltage-gated potassium channel which plays an essential role in the falling phase of physiological action potentials. KCNB1 has been reported to exert an essential role in regulating neuronal membrane potential and in stimulation action potential production and firing. KCNB1 is involved in several physiological functions through regulation and propagation of potassium current. In the CNS neurons, KCNB1 regulates neuronal excitability, the duration of action potential, and tonic spiking through mediating delayed rectifier potassium current. In cardiomyocytes, KCNB1 may regulate the duration of both the action potential of cardiomyocytes and the QT interval of heart ventricular repolarization. The inhibition of KCNB1 in mouse ventricular cardiomyocytes causes prolonged action potentials and the QT interval. In human pancreatic beta cells, KCNB1 mediates the cells action potential through regulating potassium efflux thereby participating in the regulation of calcium influx and insulin secretion. Moreover, KCNB1 can promote neuronal cells apoptosis in response to the oxidative injury induced by an increase in reactive oxygen species (ROS).

Schematic representation of potassium (K+) channel subunit. Fig.1 Schematic representation of potassium (K+) channel subunit. (Liu, 2014)

Application of KCNB1 Membrane Protein in Literature

  1. Calhoun J.D., et al. Characterization of a KCNB1 variant associated with autism, intellectual disability, and epilepsy. Neurology Genetics. 2017, 3(6):e198. PubMed ID : 29264390

    The study identifies a novel variant c.595A>Tin KCNB1 in a neurodevelopmental disorder including epilepsy. And the degree of KCNB1 protein dysfunction may affect the severity of the disease.

  2. Latypova X., et al. Novel KCNB1 mutation associated with non-syndromic intellectual disability. Journal of Human Genetics. 2016, 62(5):569-573. PubMed ID: 27928161

    The research identifies a novel de novo missense (c.1132G>C, p.V378L) mutation of KCNB1 in a patient with whole developmental delay, intellectual retardation, impaired language ability, but no performance of epilepsy until the age of 6 years old.

  3. De Kovel C.G.F., et al. Neurodevelopmental disorders caused by de novo variants in KCNB1 genotypes and phenotypes. JAMA Neurology. 2017, 74(10):1228-1236. PubMed ID: 28806457

    The study shows that the missense or loss-of-function variants in KCNB1 are associated with neurodevelopmental disorders with or without epilepsy.

  4. Wei Y., et al. Oxidation of KCNB1 potassium channels triggers apoptotic integrin signaling in the brain. Cell Death & Disease. 2017, 8(4):e2737. PubMed ID: 28383553

    The study shows that KCNB1 oxidation may contribute to integrin clustering, promoting the focal adhesion kinase (FAK) and Src/Fyn kinases recruitment and activation.

  5. Wang H.Y., et al. Role of KCNB1 in the prognosis of gliomas and autophagy modulation. Scientific Reports. 2017, 7(1):14. PubMed ID: 28144039

    The study reveals that KCNB1 can be regarded as a new glioma prognostic factor and it can suppress tumor via autophagy induction.

KCNB1 Preparation Options

To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-KCNB1 antibody development services.

As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins. Please feel free to contact us for more information.


  1. Liu W X, et al. (2014). Identifying the subfamilies of voltage-gated potassium channels using feature selection technique. International Journal of Molecular Sciences. 15(7): 12940-51.

Online Inquiry

Verification code
Click image to refresh the verification code.


USA: 45-1 Ramsey Road, Shirley, NY 11967, USA
Europe: Heidenkampsweg 58, 20097 Hamburg, Germany
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us